In this episode of Blind Spot, Zale sits down with Dr. Kieran Murphy, a renowned inventor and professor of radiology, to explore the essence of invention and creativity in medicine. Dr. Murphy shares his journey from medical innovations to his thoughts on the socio-economic factors that influence creativity. Discover how invention is not just about genius but a mindset, and learn about the challenges and triumphs in the world of medical creativity. 


Dr. Murphy's Book 'The Essence of Invention'
https://www.amazon.ca/Essence-Invention-Medicine-Joy-Creativity/dp/1459754034

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca


Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Zale sits down with Dr. Benny Jeng, head of the ZEDS study which investigated the role of longer time antiviral treatmetn for patients with HZO with ocular involvement.  They review the results of the study and disuss whether long term oral antivirals reduces zoster recurrences and the severity and duration of post-herpetic neuralgia. 

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Dr. Matthew Tennant discusses the common issue of floaters in ophthalmology, exploring their physiological basis, patient experiences, and the limitations of current treatment options. The conversation delves into traditional methods like vitrectomy and YAG vitreolysis, highlighting their risks and effectiveness. Dr. Tennant also introduces PulseMedica, a startup developing innovative technology aimed at providing a safer, non-invasive solution for treating floaters, emphasizing the potential of femto laser technology. The episode concludes with reflections on the future of floater treatment and the ongoing challenges faced by both patients and clinicians.

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Learn more about PulseMedica at https://www.pulsemedica.com/

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

In this episode, Zale delves into the world of mental performance with Dr. Cassidy Preston, a renowned mental performance coach. Discover practical mental hacks and habits that can elevate your mindset and performance to enhance your surgical practice. Dr. Preston shares insights on the importance of an inside-out approach, the power of routines, and how to maintain focus and confidence in high-pressure situations. Tune in to learn how to harness your mental game for success in any field.

Learn more about Dr. Cassidy Preston at https://drcassidypreston.com/

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca/

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Fuchs Dystrophy is an important condition to be aware before operating on any patient.  Cataract surgery, in particular, can cause someone with otherwise asymptomatic Fuchs to develop debilitating corneal edema.  Then again, not everyone with Fuchs Dystrophy is destined to develop corneal swelling.  So how do we determine which patients are at increased risk of corneal decompensation?  How do we know which Fuchs patients warrant combined cataract surgery and endothelial keratoplasty?  And as an alternative to corneal transplantation, how do procedures such as DSO or potentially even endothelial cell injection, factor into our treatment of the condition? Dr. Guillermo Rocha joins the podcast. 

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

With so may IOP-lowering drops on the market, it can be challenging to know which is the most appropriate drop to start a patient on for glaucoma.  How does one choose between the variety of prostaglandin analogs, beta blockers, alpha agonists and carbonic anhydrase inhibitors that are available?  When whould one choose monoterapy vs combination therapies?  How do the drops' side effect profiles influence one's first choice on which drop to start?  Glaucoma specialist Dr. Irfan Kherani joins the podcast.

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca 

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

With the arrival of Eyezirgan (commercial available topical ganciclovir), we now have a more readily accessible preservative-free option for treatment of HSV.  So why is Eyezirgan a potentially important new player on the market?  How does one decide between oral or topical treatments for HSV, and is there a longer-term role for antivirals in the treatment of Zoster, in addition to just HSV? Dr. Parwez Hossain joins the podcast. 

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

Giant Cell Arteritis (GCA) is one of the most dreaded diagnoses in ophthalmology; not only can it cause vision loss, but it can also be life threatening.  So what is the threshold for going down the 'GCA diagnostic path'? When should one order an ESR and CRP?  When is the concern high enough to warrant a temporal artery biopsy, and when should steroids be started?  How is temporal artery biopsy changing our diagnostic alogirthm.  Dr. Andrew Lee joins the podcast. 

This episode of the podcast is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

While the terms 'tech' and 'AI' might seem overwhelming to the average ophthalmologist and optometrist, the reality is that the future of medicine will certainly be intertwined with these technologies.  So what exactly is 'health tech' in the context of eye care?  Dr. Lisa Jagan is the founder of Lid Express, an online platform that allows patients to submit photos of eyelid lesions to be reviewed by a team of oculopplastic surgeons in an expedited fashion.  She joins the podcast to share her experience developing an oculoplastics tech platform and the lessons she has learned along the way.  

Lid Express
Website - https://clarityeye.ca/services/lid-express/
Email - [email protected]
Instagram @lidexpress

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.

As preservative-free eye drops become more common, one has to wonder why it is so important to reduce our use of preservatives.  What kind of toxicity do preservatives wreak on the eye?  And without preservatives, are eye drops still as effective and resistant to infection?  Especially in the realms of dry eye and glaucoma, how have preservative free drops started to change the landscape, and what can we expect moving forward? Denmark's Dr. Miriam Kolko joins the podcast. 

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.